MADRID, Feb. 11, 2026 /PRNewswire/ — ArisGlobal, an AI-first technology company at the forefront of Life Sciences and creator of LifeSphere®, has announced fiveMADRID, Feb. 11, 2026 /PRNewswire/ — ArisGlobal, an AI-first technology company at the forefront of Life Sciences and creator of LifeSphere®, has announced five

ArisGlobal Announces XDI NavaX Data Intelligence, Three New Agents, and NavaX Translation

2026/02/11 16:30
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

MADRID, Feb. 11, 2026 /PRNewswire/ — ArisGlobal, an AI-first technology company at the forefront of Life Sciences and creator of LifeSphere®, has announced five significant new product offerings to drive cross-functional operationalization of AI. On day one of Breakthrough 2026, its annual industry event, the company unveiled XDI, its next‑generation data intelligence cortex, three new AI agents, and NavaX Translation for PV case data intake workflows.

XDI – Explainable AI and evidential alignment beyond functional boundaries

XDI is ArisGlobal’s next‑generation data intelligence cortex that can access data from multiple functions and systems to enable consistent, explainable decisions within and across the pharma R&D enterprise. Unlike tools that simply accelerate steps within a single workflow, XDI creates a system-agnostic foundation that unifies meaning, context, and intent – ensuring that decisions across Safety, Regulatory, Clinical, Quality, Manufacturing, and all other functions are grounded in shared meaning, aligned evidence, and uniform governance. This will promote confident AI adoption and operationalization, while reducing risk and interpretive drift between teams and use cases.

New agents for Regulatory Intelligence, Change Distribution, and Signals

ArisGlobal has also expanded its NavaX Agents Suite portfolio with three powerful new agents;

  • Intelligence Agents transforms submission quality by automatically interpreting regulatory guidelines, converting them into precise rule checklists, and assessing dossiers from LifeSphere Submissions with clear compliance evaluations, justifications, and confidence scores.
  • Distribution Agents deliver continuous compliance validation by automatically consuming evolving regulatory guidelines, validating them against internal distribution logic, and triggering governed change workflows as discrepancies arise.
  • Signals Agents is an intelligent assistant which interprets user intent, determines the best analytical approach, and dynamically plans and executes workflows. An active intelligence partner, it harnesses a reasoning-based orchestration layer spanning safety, data, analytics, and expert judgment.

NavaX Translation – Transforming global case data intake workflows

ArisGlobal now supports certified translation capabilities integrated directly into case data intake workflows, via a strategic partnership with TransPerfect Life Sciences. Intelligent language detection routes non-English safety forms instantly for translation using pharma-specific language models and expert linguists. The seamless API integration returns translated forms directly into LifeSphere, eliminating manual effort and dramatically accelerating global pharmacovigilance. By combining NavaX with TransPerfect, translation management time drops from roughly five hours per case to under a minute—delivering unmatched automation, speed, and accuracy in the market.

“The challenge for life sciences isn’t just adopting AI – it’s operationalizing it at scale with consistency, governance, and real business impact. With these latest product enhancements, we’re continuing to enable organizations to move from experimentation to production, turning AI into a reliable foundation for enterprise decision-making,” commented Aman Wasan, CEO of ArisGlobal.

“We’re witnessing a fundamental shift in how technology empowers life sciences teams. These innovations represent the evolution from automating individual tasks to orchestrating intelligence across entire operational ecosystems, enabling smarter decisions, faster insights, and truly scalable AI adoption,” said Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal.

Breakthrough 2026, held in Madrid, Spain, brings together top executives, industry leaders, and experts to explore the theme of “Operationalizing AI”, showcasing how proven AI use cases are transforming into everyday practice across life sciences.

For more information, visit https://www.arisglobal.com/breakthrough or follow ArisGlobal on LinkedIn.

About ArisGlobal

ArisGlobal is a leading life sciences technology company and provider of cloud-based software solutions for pharmacovigilance, regulatory affairs, quality management, and medical affairs. LifeSphere®, the company’s unified product platform, delivers a powerful combination of domain expertise, advanced technology, and analytics to help life sciences organizations transform compliance into a strategic advantage. ArisGlobal serves more than 300 customers globally, including many of the world’s top pharmaceutical, biotechnology, and medical device companies. For more information, visit www.arisglobal.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/arisglobal-announces-xdi-navax-data-intelligence-three-new-agents-and-navax-translation-302684836.html

SOURCE ArisGlobal

Market Opportunity
CROSS Logo
CROSS Price(CROSS)
$0.13438
$0.13438$0.13438
+3.80%
USD
CROSS (CROSS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Pi Network Visa Integration Logic Suggests Potential Shift in Global Payment Liquidity

Pi Network Visa Integration Logic Suggests Potential Shift in Global Payment Liquidity

Alleged Visa Related Logic in Pi Network Code Sparks Debate Over Future of Global Payment Systems Recent discussions within the Pi Network and broader bloc
Share
Hokanews2026/04/26 15:23
The New Geometry of Global Trade: Why Asia Is Winning in the AI Era

The New Geometry of Global Trade: Why Asia Is Winning in the AI Era

Global trade is not collapsing—it is transforming, and Asia is at the center of this... The post The New Geometry of Global Trade: Why Asia Is Winning in the AI
Share
Bitcoin News Asia2026/04/26 15:01
Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC

Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC

The post Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC appeared on BitcoinEthereumNews.com. Franklin Templeton CEO Jenny Johnson has weighed in on whether the Federal Reserve should make a 25 basis points (bps) Fed rate cut or 50 bps cut. This comes ahead of the Fed decision today at today’s FOMC meeting, with the market pricing in a 25 bps cut. Bitcoin and the broader crypto market are currently trading flat ahead of the rate cut decision. Franklin Templeton CEO Weighs In On Potential FOMC Decision In a CNBC interview, Jenny Johnson said that she expects the Fed to make a 25 bps cut today instead of a 50 bps cut. She acknowledged the jobs data, which suggested that the labor market is weakening. However, she noted that this data is backward-looking, indicating that it doesn’t show the current state of the economy. She alluded to the wage growth, which she remarked is an indication of a robust labor market. She added that retail sales are up and that consumers are still spending, despite inflation being sticky at 3%, which makes a case for why the FOMC should opt against a 50-basis-point Fed rate cut. In line with this, the Franklin Templeton CEO said that she would go with a 25 bps rate cut if she were Jerome Powell. She remarked that the Fed still has the October and December FOMC meetings to make further cuts if the incoming data warrants it. Johnson also asserted that the data show a robust economy. However, she noted that there can’t be an argument for no Fed rate cut since Powell already signaled at Jackson Hole that they were likely to lower interest rates at this meeting due to concerns over a weakening labor market. Notably, her comment comes as experts argue for both sides on why the Fed should make a 25 bps cut or…
Share
BitcoinEthereumNews2025/09/18 00:36

Roll the Dice & Win Up to 1 BTC

Roll the Dice & Win Up to 1 BTCRoll the Dice & Win Up to 1 BTC

Invite friends & share 500,000 USDT!